Toggle light / dark theme

It might seem as though humans have little in common with the lowly yeast cell. Humans have hair, skin, muscles, and bones, among other attributes. Yeast have, well, none of those things.

But besides their obvious differences, yeast and humans, and much of life for that matter, have a great deal in common, especially at the cellular level. One of these commonalities is the our cells use to make RNA copies of sections of our DNA. The enzyme slides along a strand of DNA that has been unpacked from the chromosome in which it resides, to “read” the genetic code, and then assembles an RNA strand that contains the same code. This copying process, known as transcription, is what happens at a when a gene is activated in an organism. The enzyme responsible for it, RNA polymerase, is found in all (cells with a nucleus) and it is essentially the same in all of them, whether the cells are from a redwood, an earthworm, a caribou, or a mushroom.

That fact has presented a mystery for scientists, though: Although the DNA in a yeast cell is different in many ways from the DNA in a human cell, the same enzyme is able to work with both. Now, a team of Caltech researchers has discovered one way this happens.

This discussion includes Dr. Williams’ work with gene therapy, cancer research, and follistatin — a myostatin inhibitor. he administered to himself years ago.

Dr. Williams, CMO of BioViva Science, is a radiologist with a passion for gene and cellular therapies that can be administered under image guidance. He also has an interest in image guided cancer therapies. He did research for several years with adenoviral vector technology for the treatment of cancer. He has spent the last five years involved in research using AAV technology. Dr. Williams obtained his medical degree from Louisiana State University and completed an internship in Internal Medicine followed by a residency in Radiology at The University Of South Alabama. In residency, he was selected for the RSNA Research Fellow award.

He is board certified by The American Board of Radiology with additional training in image guided cancer and spine procedures. His research interest is in gene therapy and re-programming of stem cells. He also has research interests in the use of CT and MRI guidance for minimally invasive procedures related to the spine and treatment of cancer.

Wlliams Cancer Institute:
https://williamscancerinstitute.com/

Charlie Ilsley, the 13 year old being treated by Dr. Williams:
https://www.henleystandard.co.uk/news/home/152534/family-to-…tment.html

Learn more about follistatin gene therapy :

Linus Torvalds, the creator of Linux, offered up some interesting thoughts on Intel’s Advanced Vector Extensions 512 (AVX-512) instruction set, calling it a “power virus” that was only created to make the company’s CPU hardware perform well in benchmarks. He also admitted to being “biased” and “grumpy” in his assessment.

His comments came in a mailing list (via Phoronix) discussing an article suggesting AVX-512 might not be part of Intel’s upcoming Alder Lake architecture. If that comes to pass, it will be just fine by Torvalds.

Tired of the coronavirus? Well, the good news is that there are several vaccines in development that are in their final phase of clinical testing before they can be approved for public usage. The bad thing, however, is the fact that there are only so many doses each vaccine manufacturer can make- meaning solving the pandemic will be as much a problem of distribution and manufacturing as it is research and development.

PS: The stock footage from this photo comes from Videvo!

Discord Link: https://discord.gg/brYJDEr
Patreon link: https://www.patreon.com/TheFuturistTom
Please follow our instagram at: https://www.instagram.com/the_futuris
For business inquires, please contact Technovisionaries1205@gmail.com

Glioblastoma is the most aggressive type of cancer that begins with the brain and develops from astrocytes, star-shaped brain cells that help protect the brain from diseases in the blood and provide the brain’s neurons with nutrients, with around 12,000 cases diagnosed in the United States each year. Glioblastoma cells have more genetic abnormalities than the cells of other types of astrocytoma brain cancer. Now researchers from the University of Virginia (UVA) School of Medicine report they have identified an oncogene responsible for this deadly cancer.

Their study, “A cytoskeleton regulator AVIL drives tumorigenesis in glioblastoma,” is published in Nature Communications and led by Hui Li, PhD, associate professor, pathology, at the University of Virginia School of Medicine and the UVA Cancer Center.

“Glioblastoma is a deadly cancer, with no effective therapies. Better understanding and identification of selective targets are urgently needed. We found that advillin (AVIL) is overexpressed in all the glioblastomas we tested including glioblastoma stem/initiating cells, but hardly detectable in non-neoplastic astrocytes, neural stem cells or normal brain,” the researchers wrote.